Azide-functionalized nanoparticles as quantized building block for the design of soft-soft fluorescent polystyrene core – PAMAM shell nanostructures Krystyna Baczko,a Hélène Fensterbank,a Bruno Berini,b Nadège Bordage,c Gilles Clavier,c Rachel Méallet-Renault,c,d Chantal Larpenta and Emmanuel Allard*a a Institut Lavoisier de Versailles UMR-CNRS 8180, Université de Versailles-Saint-Quentinen-Yvelines. 45 avenue des Etats-Unis, 78035 Versailles cedex, France. E-mail: emmanuel.allard@uvsq.fr; Tel: (+33) 139-25-44-12 Groupe d’Etude de la Matière Condensée UMR-CNRS 8635, Université de Versailles-SaintQuentin-en-Yvelines. 45 avenue des Etats-Unis, 78035 Versailles cedex, France. b c PPSM, ENS Cachan, CNRS. 61 avenue du Président Wilson, 94230 Cachan Cedex, France. Present address : Institut des Sciences Moléculaires d’Orsay, CNRS-Université Paris-Sud (UMR 8214), Bât 350, 91405 Orsay Cedex, France d S-1 Tables of Contents Pages Figure S1: Structures and numbering of Bodipy 5 and 6 used for 1H and 13C NMR signals assignments. S4 Figure S2: Structures and numbering of PAMAM_[CO2CH3]16 (3-G2.5) and PAMAM_[NH2]16 (3-G3) used for 1H and 13C NMR signals assignments. S4 Synthesis of functionalized nanoparticles NP_Cl and NP_N3 S5 Table S1: Characteristics of chlorobenzyl- and azide-functionalized nanoparticles S6 Synthesis of amino-terminated PAMAM[NH2]2 G0 S6 Synthesis of amino-terminated PAMAM[NH2]4 (1-G1) S7 Synthesis of amino-terminated PAMAM[NH2]8 (2-G2) S8 Synthesis of functionalized nanoparticles NP_PAMAM[NH2]4 S9 Synthesis of functionalized nanoparticles NP_PAMAM[NH2]8 S10 Synthesis of functionalized nanoparticles NP_PAMAM[NH2]16 S11 Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]8 (two steps) S11 Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]16 (two steps) S12 Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]4 (one pot) S13 Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]8 (one pot) S14 Figure S3: AFM Topographic images obtained at pH = 7 of NP_Bodipy_PAMAM[NH2]8 (A) and NP_Bodipy_PAMAM[NH2]16 (B) S14 Figure S4. Absorption (lines) and Fluorescence emission (dotted lines) spectra (exc = 495nm) of 6 diluted in DTAB 5 wt%. S15 Figure S5. Absorption (A) and Fluorescence emission (B) spectra (exc = 495nm) of NP_Bodipy_PAMAM[NH2]4 diluted in DTAB 1 wt% for pH values from 1.1 to 9.3 S16 Figure S6. Absorption (A) and Fluorescence emission (B) spectra (exc = 495nm) of NP_Bodipy_PAMAM[NH2]8 diluted in water for pH values from 1.1 to 9.3 S17 Figure S7. Absorption (A) and Fluorescence emission (B) spectra (exc = 495nm) of NP_Bodipy_PAMAM[NH2]16 diluted in water for pH values from 1.1 to 9.3 S18 Figure S8. Estimation of the radius of benzyl triazole functionalized amino-terminated PAMAM dendron (1-G1) and (2-G2) S19 S-2 Figure S9 and S10: Estimation of the radius of benzyl triazole functionalized amino-terminated PAMAM dendron (3-G3) S20 Table S2: Estimation of the maximum number (Nmax) of amino-terminated PAMAM dendrons that could be grafted on the NP surface S21 Table S3: Estimation of the number of Bodipy grafted on the NP surface S22 S-3 Figure S1. Structures and numbering of Bodipy derivatives 5 and 6 used for 1H and 13C NMR signals assignments. PAMAM_[NH2]16 (3-G3) PAMAM_[CO2CH3]16 (3-G2.5) Figure S2. Structures and numbering of esters terminated PAMAM_[CO2CH3]16 (3-G2.5) and amino terminated PAMAM_[NH2]16 (3-G3) used for 1H and 13C NMR signals assignments. S-4 Synthesis of functionalized nanoparticles NP_Cl and NP_N3 Cl Synthesis of chlorobenzyl-functionalized nanoparticles NP_Cl A microemulsion was prepared into a reactor by progressive addition, upon gentle magnetic stirring, of a mixture of monomers (styrene/divinylbenzene/vinylbenzylchloride : 3.50 g (33.6 mmol) / 4.50 g (34.8 mmol) / 1.85 g (12.2 mmol), respectively) and DMPA (341 mg, 1.3 mmol) to 187 g of a 17.5-wt% aqueous solution of DTAB. The resulting microemulsion was degassed with nitrogen for 30 min and the polymerization was then carried out under white light irradiation using two 60 W lamps at room temperature under nitrogen for 24 h. A stable translucent suspension of nanoparticles was obtained. Chemical composition of the polymer: C, 84.30; H, 7.47; Cl, 3.85 % corresponding to a chloride content of 1.08 mmol/g of polymer. Mean diameter: 17 nm (PDI: 0.007). IR (KBr, ν, cm-1): 3056, 3023 (C-H arom), 2922 (a C-H), 2853 (s C-H), 1600, 1498, 1448 (C=C), 834, 796, 759, 702 (-C-H et C=C). NP_Cl bis Chemical composition of the polymer: C, 78.36; H, 8.26; Cl, 3.08 % corresponding to a chloride content of 0.87 mmol/g of polymer. Mean diameter: 16 nm (PDI: 0.014). N3 Synthesis of azide-functionalized nanoparticles NP_N3 Azide-coated nanoparticles NP_N3 were prepared by adding 27 mL an aqueous solution of sodium azide (8.04 g, 123.7 mmol) to 218 g of the freshly prepared crude suspension of NP_Cl. The resulting suspension was stirred at room temperature for one week. The excess of sodium azide was then removed by dialysis through a porous cellulose membrane (MWCO 12000-14000D) toward an aqueous solution of DTAB (5 wt %) leading to a aqueous suspension of azide-functionalized nanoparticles NP_N3. The suspension was kept in the presence of DTAB (15 wt%). Polymer particle content in suspension was 1.5 wt%. Chemical composition: C, 85.65; H, 7.26; N, 1.92 % corresponding to an azide content of 0.46 mmol/g of polymer. Mean diameter (QELS): 16 nm (PDI: 0.141). IR (KBr, ν, cm-1): 3083, 3058, 3025 (C-H arom), 2923 (a C-H), 2852 (s C-H), 2097 (N3), 1602, 1493, 1452 (C=C), 837, 797, 761, 700 (-C-H et -C=C). NP_N3 bis Polymer content in suspension was 4.4 wt%. Chemical composition: C, 82.96; H, 7.17; N, 2.18 % corresponding to an azide content of 0.53 mmol/g of polymer. Mean diameter (QELS): 15 nm (PDI: 0.033). S-5 Table S1. Characteristics of chlorobenzyl- and azide-functionalized nanoparticles. Entries elemental analysis loada (mmol/g of polymer) NP_Cl NP_N3 a. b. %C: 84.03 %H: 7.47 %Cl: 3.85 %C: 85.65 %H: 7.26 %N: 1.92 D (nm) b, c [PDI] Chloride 1.08 17 [0.007] Azide content 0.46d 16 [0.141] Deduced from elemental analysis. The suspension was diluted one hundred times so that the content of DTAB in the suspension was close to 0.15 wt%. Particle diameter (D) and its polydispersity index (PDI) determined from QELS. That corresponds to about 620 N3 per NP. c. d. Procedure for the preparation PAMAM[NH2]n (denoted as G0, G1, and G3). Amino-terminated PAMAM dendrons PAMAM[NH2]n were prepared using procedures described in the literature. Synthesis of amino-terminated PAMAM[NH2]2 (G0) CO2CH3 3 1 N 2 5 4 CO2CH3 6 7 Propargylamine (2.3 mL, 360 mmol) was mixed with 8 mL of dry methanol and cooled to 0°C. To this cooled solution was added dropwise a 50% methanol (v/v) solution of methyl acrylate (MA, 13 mL, 140 mmol) in methanol dry (15 mL) over a period of 30 min. The reaction mixture was stirred 48h at room temperature. The excess of methyl acrylate and methanol were then removed under vacuum at 60-70°C to afford the ester terminated PAMAM dendron (G-0.5) as a light yellow oil (99 % yield). 1H NMR (CDCl3, δ, ppm): 2.17 (t, J 2.3, 1H, H1), 2.42 (t, J 7.1, 4H, H5), 2.79 (t, J 7.0, 4H, H4), 3.37 (d, J 2.3, 2H, H3), 3.62 (s, 6H, H7); 13C NMR (CDCl3, δ, ppm): 32.7 (C5), 41.7 (C3), 48.8 (C4), 51.4 (C7), 73.2 (C1), 77.9 (C2); 172.5 (C6); ESI-HRMS: m/z calcd. for C11H18NO4: 228.1236[M+ H]+; found 228.1236. NH2 O NH 3 1 2 N 5 4 6 H N O 8 7 NH2 Ethylenediamine (EDA, 35 mL, 525 mmol) was mixed with 35 mL of methanol dry and cooled to 0°C. To this cooled solution was added dropwise a methanol solution (15 mL) of ester terminated PAMAM dendron (G-0.5) (8 g, 35 mmol). The reaction mixture was stirred under nitrogen at 0°C for 30 min, then at room temperature for three days. Most of the excess of ethylenediamine and methanol was removed under vacuum. The remaining ethylenediamine was removed by azeotroping mixture of toluene and methanol 3/1 (v/v) then methanol to afford 10.4 g of S-6 amino-terminated PAMAM dendron (G0) as a light yellow viscous oil (100% yield). 1H NMR (D2O, δ, ppm): 2.43 (t, J 7.2, 4H, H5), 2.69 (t, J 6.2, 4H, H8), 2.83 (t, J 7.2, 4H, H4), 3.22 (t, J 6.2, 4H, H7), 3.33 (s, 1H, H1), 3.40 (s, 2H, H3); 13C NMR (D2O/CD3CN, δ, ppm): 33.2 (C5), 39.7 (C7), 41.2 (C3), 41.7 (C8), 48.9 (C4), 77.6 (C1), 174.8 (C6); IR (neat, ν, cm-1): 3275, 3066 (N-H), 2927 (as C-H), 2837 (s C-H), 1639 (C=O amide), 1542 ( NH); ESI-HRMS: m/z calcd. for C13H26N5O2: 284.2087[M+ H]+; found 284.2090. Synthesis of amino-terminated PAMAM[NH2]4 (1-G1) Starting from amino-terminated PAMAM[NH2]2 (G0) (7 g, 24.7 mmol) and MA (13.4 mL, 148 mmol), ester-terminated PAMAM[CO2CH3]4 (G0.5) was isolated after purification by chromatography (SiO2, eluent: CHCl3/MeOH 9.5/0.5, then 9/1) as a pale yellowish oil (11.3 g, 73%). 1H NMR (CDCl3, δ, ppm): 2.17 (t, J 2.3, 1H, H1), 2.35 (t, J 6.5, 4H, H5), 2.41 (t, J 6.6, 8H, H10), 2.52 (t, J 5.8, 4H, H8), 2.73 (t, J 6.6, 8H, H9), 2.82 (t, J 6.5, 4H, H4), 3.26 (m, 4H, H7), 3.43 (d, J 2.3, 2H, H3), 3.64 (s, 12H, H12), 7.08 (m, 2H, CONH) ; 13C NMR (CDCl3, δ, ppm): 32.5 (C10), 33.7 (C5), 36.9 (C7), 41.0 (C3), 49.2 (C9), 49.3 (C4), 51.5 (C12), 52.9 (C8), 73.3 (C1), 77.8 (C2), 171.7 (C6), 172.8 (C11); IR (neat, ν, cm-1): 3276 (N-H), 2951 (as C-H), 2830 (s C-H), 1729 (C=O ester), 1639 (C=O amide), 1528 ( NH); ESI-HRMS: m/z calcd. for C29H50N5O10: 628.3558[M+ H]+; found 628.3554 . Starting from ester-terminated PAMAM[CO2CH3]4 (G0.5) (8.03 g, 12.7 mmol) and EDA (25 mL, 374 mmol), amino-terminated PAMAM[NH2]4 (1-G1) was isolated without further purification as a pale yellowish oil (9.13 g, 97 %). 1H NMR (D2O, δ, ppm): 2.46 (t, J 7.0, 12H, H5, H10), 2.67 (t, J 6.6, 4H, H8), 2.83 (m, 20H, H4, H9, H13), 3.32 (m, 12H, H7, H12), 3.35 (s, 1H, H1), S-7 3.46 (s, 2H, H3); 13C NMR (D2O/CD3CN, δ, ppm): 33.4 (C10), 33.8 (C5), 37.4 (C7), 40.3 (C13), 41.8, 42.1 (C3, C12), 49.4, 49.5 (C4, C9), 51.8 (C8), 175.0, 175.7 (C6, C11); IR (neat, ν, cm-1): 3283, 3085 (NH), 2934 (as C-H), 2822 (s C-H), 1629 (C=O amide), 1549 ( NH); ESI-HRMS: m/z calcd. for C33H66N13O6: 740.5259[M+ H]+; found 740.5262. Synthesis of amino-terminated PAMAM[NH2]8 (2-G2) Starting from amino-terminated PAMAM[NH2]4 (1-G1) (6.0 g, 8.1 mmol) and MA (8.8 mL, 97.3 mmol), ester-terminated PAMAM[CO2CH3]8 (G1.5) was isolated after purification by chromatography (SiO2, eluent: AcOEt/MeOH 6/1, then 1/1) as a pale yellowish oil (7.0 g, 60 %). 1H NMR (CDCl3, δ, ppm): 2.20 (t, J 2, 1H, H1), 2.40 (m, 28H, H5, H10, H15), 2.53 (t, J 5.9, 8H, H13), 2.60 (t, J 5.9, 4H, H8), 2.75 (t, J 6.7 24H, H9, H14), 2.82 (t, J 6.0, 4H, H4), 3.28 (m, 12H, H7, H12), 3.45 (d, J 2, 2H, H3), 3.66 (s, 24H, H17), 7.08 (t, J 5.1, 4H, CONH); 7.74 (m, 2H, CONH); 13C NMR (CDCl3, δ, ppm): 32.6, 33.7, 33.8 (C5, C10, C15), 37.2, 37.3 (C7, C12), 41.0 (C3), 49.2, 49.4, 49.9 (C4, C9, C14), 51.6 (C17), 52.5, 52.9 (C8, C13), 73.4 (C1), 78.0 (C2), 172.2, 172.3 and 173.0 (C6, C11, C16); IR (neat, ν, cm-1): 3286. 3079 (N-H), 2951 (as C-H), 2824 (s C-H), 1732 (C=O ester), 1642 (C=O amide), 1536 ( NH); ESI-HRMS: m/z calcd. for C65H114N13O22: 1428.8202[M+ H]+; found 1428.8690. S-8 Starting from ester-terminated PAMAM[CO2CH3]8 (G1.5) (6.2 g, 4.3 mmol) and EDA (17 mL, 254 mmol), amino-terminated PAMAM[NH2]8 (2-G2) was obtained without further purification as a pale yellowish oil (6.92 g, 100 %). 1H NMR (D2O, δ, ppm): 2.42 (m, 28H, H5, H10, H15), 2.61 (t, J 6.6, 12H, H8, H13), 2.78 (m, 44H, H4, H9, H14, H18), 3.11 (s, 1H, H1), 3.25 (m, 30H, H7, H12, H17, H3); 13C NMR (D2O/CD3CN, δ, ppm): 33.3 (C5, C10, C15), 37.3 (C7, C12), 40.3 (C3, C18), 41.6 (C17), 49.6 (C4, C9, C14), 51.8 (C8, C13), 175.3, 175.7 (C6, C11, C16); IR (neat, ν, cm-1): 3276,3069 (N-H), 29327 (as C-H), 2832 (s C-H), 1634 (C=O amide), 1544 ( NH); ESIHRMS: m/z calcd. for C73H146N29O14: 1653.1604 [M+H]+; found 1653.1614. Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]n using a two steps process Synthesis of functionalized nanoparticles NP_PAMAM[NH2]4 O HN N O NH2 HN O NH NH2 N N N N NH O N O HN O NH2 HN NH2 Amino-terminated PAMAM dendron (1-G1) (207 mg, 0.28 mmol) was added to 8.05 g of the aqueous suspension of azide-functionalized nanoparticles NP_N3 bis (4.4 wt% in 15% DTAB). Then, 2 mL of a freshly prepared aqueous solution of CuSO4 (74 mg, 0.46 mmol) and sodium ascorbate (167 mg, 0.84 mmol) was added. The resulting yellow suspension was stirred at room temperature for 5 days. Then, the mixture was dialyzed with an S-9 aqueous solution of DTAB (5 wt%) and EDTA (0.05 M), then with a solution of DTAB (1 wt%, ten times) using a porous cellulose membrane (MWCO 12000-14000 D) leading to a stable translucent aqueous suspension of PAMAM functionalized nanoparticles NP_PAMAM[NH2]4. Polymer particle content in suspension was 1.8 wt%. IR (KBr, ν, cm-1): 3416 (N-H), 3081, 3052, 3027 (C-H arom), 2921 (as C-H), 2852 (s C-H), 2092 (N3), 1654 (C=O amide), 1597 (C=C), 1541 ( NH), 836, 796, 763, 702 (-C-H et -C=C). Amino-terminated functionalized nanoparticles NP_PAMAM[NH2]8 and NP_PAMAM[NH2]16 were prepared using the same procedure as above. NP_PAMAM[NH2]8 NH2 O O NH H N N HN O O N O NH HN O NH NH2 NH2 N NH N O N N N NH2 NH O N O O HN O NH2 NH N HN N O NH O HN O NH NH2 NH2 H2N Starting from (2-G2) (315 mg, 0.19 mmol), 8.0 g of aqueous suspension of NP_N3 bis, 2 mL of aqueous solution of CuSO4 (74 mg, 0.46 mmol) and sodium ascorbate (167 mg, 0.84 mmol). Polymer particle content in suspension was 1.2 wt%. IR (KBr, ν, cm-1): 3428 (N-H), 3078, 3056, 3019 (C-H arom), 2921 (as C-H), 2847 (s C-H), 2092 (N3), 1658 (C=O amide), 1605 (C=C), 1544 ( NH), 833, 792, 764, 698 (-C-H et -C=C). S-10 NP_PAMAM[NH2]16 H 2N NH O NH2 HN N O O NH2 NH NH O O N HN O O O H N O N N N N NH O N O NH2 O H N HN N N H2 N N H O NH O O N H 2N NH O N O NH2 HN O NH2 NH O NH NH2 NH HN N HN O NH2 N H N O O NH2 NH2 NH O O O HN H N O O N H NH N NH N N O NH NH2 NH2 O HN N O H N N HN HN H2N Starting from (3-G3) (661 mg, 0.19 NH2 mmol), 8.0 g of aqueous suspension of NP_N3 bis, 2 mL of aqueous solution of CuSO4 (75 mg, 0.46 mmol) and sodium ascorbate (167 mg, 0.84 mmol). Polymer particle content in suspension was 1.1 wt%. IR (KBr, ν, cm-1): 3432 (N-H), 3077, 3052, 3019 (C-H arom), 2917 (as C-H), 2848 (s C-H), 2092 (N3), 1654 (C=O amide), 1544 ( NH), 837, 788, 760, 694 (-C-H et -C=C). Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]8 NH2 O O NH H N N HN O O NH HN N O O NH N NH N F N B F N O N NN NH2 NH2 O N N N NH2 NH O N O O HN O NH2 NH N HN N O HN O NH H 2N NH O NH2 NH2 Alkyne-Bodipy 5 (38 mg, 0.087 mmol) was added to 12 g of the aqueous suspension of NP_PAMAM[NH2]8 (1.2 wt% in 5 % DTAB), the resulting mixture was stirred at room temperature for 2 hours. Then, 1 mL of a freshly prepared aqueous solution of CuSO4 (17 mg, 0.104 mmol) and sodium ascorbate (40 mg, 0.20 mmol) was added. The resulting suspension was stirred at room temperature for 6 days. Then, the mixture was dialyzed against an aqueous solution of DTAB (5 wt%) and EDTA (0.05 M) and finally with DTAB (5 S-11 wt%) using a porous cellulose membrane (MWCO 12000-14000 D). The suspension was filtered and purified by dialysis against an aqueous solution of DTAB (5 wt%) using an ultrafiltration device (Vivascience, Vivaspin concentrator 20, 50 000 MWCO PES), leading to a stable translucent aqueous suspension of Bodipy-functionalized nanoparticles NP_Bodipy_PAMAM[NH2]8. Polymer particle content in suspension was 1.6 wt%. IR (KBr, ν, cm-1): 3432 (N-H), 3081, 3052, 3023 (C-H arom), 2921 (as C-H), 2852 (s C-H), 1650 (C=O amide), 1601 (C=C), 1540 ( NH), 833, 792, 760, 702 (-CH et -C=C). Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]16 H 2N NH O NH2 HN N O O O NH N N H O O N N N N NN N NH O N O O O HN O H N HN N O N H O NH N HN NH O O O N N O HN O NH NH2 N H NH2 NH NH2 NH2 O HN H2N O N NH NH2 O HN NH2 NH2 NH N O H 2N H N O O N H NH O NH N N N F N B F N NH2 NH2 O O H N O NH H N O H N N O NH N HN O NH2 H2N NH2 Aqueous suspension of NP_Bodipy_PAMAM[NH2]16 was prepared using the same procedure as above. Starting from alkyne-Bodipy 5 (29 mg 0.066 mmol), 5 g of aqueous suspension of NP_PAMAM[NH2]16, 1 mL of aqueous solution of CuSO4 (13 mg, 0.079 mmol) and sodium ascorbate (30 mg, 0.152 mmol). Polymer particle content in suspension was 1.1 wt%. IR (KBr, ν, cm-1): 3440 (NH), 3080, 3055, 3017 (C-H arom), 2920 (a C-H), 2849 (s C-H), 1650 (C=O amide), 1538 ( NH), 832, 800, 758, 702 (-C-H et -C=C). S-12 Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]n using a one-pot process Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]4 O HN N O NH2 HN O NH NH2 N N N N F N B F N O NH O N NN N O HN O NH2 HN NH2 Amino-terminated PAMAM dendron (1-G1) (230 mg, 0.31 mmol) was added to 30 g of the aqueous suspension of azidefunctionalized nanoparticles NP_N3 (1.5 wt% in 15% DTAB). Then, 2 mL of a freshly prepared aqueous solution of CuSO4 (80 mg, 0.50 mmol) and sodium ascorbate (167 mg, 0.84 mmol) was added. The resulting suspension was stirred at room temperature for 4 days. Alkyne-Bodipy 5 (80 mg, 0.183 mmol) was then added. The resulting mixture was stirred at room temperature for 2h before addition of 2 mL of a freshly prepared aqueous solution of CuSO4 (70 mg, 0.44 mmol) and sodium ascorbate (167 mg, 0.84 mmol). The resulting red suspension was stirred at room temperature for 3 days. Aqueous suspension was then purified using the same procedure as for the two-steps process and led to a stable translucent aqueous suspension of Bodipy-functionalized nanoparticles NP_Bodipy_PAMAM[NH2]4. Polymer particle content in suspension was 1.1 wt%. Chemical composition: C, 77.21; H, 7.46; N, 3.71; B, 0.21 %; Mean diameter (QELS): 20 nm (PDI: 0.063); IR (KBr, ν, cm-1): 3080, 3055, 3024 (C-H arom), 2922 (as C-H), 2851 (s C-H), 1650 (C=O amide), 1601 (C=C), 1541 ( NH), 834, 796, 760, 700 (-C-H et -C=C). S-13 Synthesis of functionalized nanoparticles NP_Bodipy_PAMAM[NH2]8 NH2 O O NH H N N HN O O N O NH HN O NH N NH N F N B F N O N NN NH2 NH2 O N N N NH2 NH O N O O NH HN O NH2 N HN N NH O O O HN NH H 2N NH2 NH2 Aqueous suspension of NP_Bodipy_PAMAM[NH2]8 was prepared using the same procedure as above. Starting from 2-G2 (512 mg, 0.31 mmol), 30 g of aqueous suspension of NP_N3, 2 mL of aqueous solution of CuSO4 (80 mg, 0.50 mmol) and sodium ascorbate (188 mg, 0.95 mmol), followed by addition of alkyne-Bodipy 5 (81 mg 0.19 mmol) and 2 mL of aqueous solution of CuSO4 (70 mg, 0.44 mmol) and sodium ascorbate (167 mg, 0.84 mmol). Polymer particle content in suspension was 1.15 wt%. Chemical composition: C, 70.21; H, 7.59; N, 7.17; B, 0.12 %; Mean diameter (QELS): 24 nm (PDI: 0.172); IR (KBr, ν, cm-1): 3080, 3054, 3028 (C-H arom), 2921 (as C-H), 2846 (s C-H), 1649 (C=O amide), 1541 ( NH), 833, 795, 760, 700 (-C-H et -C=C). Figure S3. AFM Topographic images obtained at pH = 7 of NP_Bodipy_PAMAM[NH2]8 (A) and NP_Bodipy_PAMAM[NH2]16 (B) using the tapping mode onto a mica substrate. S-14 Figure S4. Absorption (full lines) and Fluorescence emission (dotted lines) spectra (exc = 495nm) of 6 diluted in DTAB 5 wt%. S-15 Figure S5. Absorption (A) and Fluorescence emission (B) spectra corrected from absorption (exc = 495nm, slits width 2.2 nm) of aqueous suspension of NP_Bodipy_PAMAM[NH2]4 (diluted 1000 times in 1 wt% DTAB aqueous solutions) for pH values ranging from 1.1 to 9.3. The pH has been adjusted for pH = 1.1 with HCl (10-1 M); pH = 3.0 with HCl (10-3 M); pH = 5.0, 6.9 and 9.3 with phosphate buffers. S-16 Figure S6. Absorption (A) and Fluorescence emission (B) spectra corrected from absorption (exc = 495nm, slits width 3.0 nm) of aqueous suspension of NP_Bodipy_PAMAM[NH2]8 (diluted 400 times in water) for pH values ranging from 1.1 to 9.3. The pH has been adjusted for pH = 1.1 with HCl (10-1 M); pH = 2.9 with HCl (10-3 M); pH = 5.0, 7.0 and 9.3 with phosphate buffers. S-17 Figure S7. Absorption (A) and Fluorescence emission (B) spectra corrected from absorption (exc = 495nm, slits width 3.25 nm) of aqueous suspension of NP_Bodipy_PAMAM[NH2]16 (diluted 400 times in water) for pH values ranging from 1.1 to 9.3. The pH has been adjusted for pH = 1.1 with HCl (10-1 M); pH = 2.9 with HCl (10-3 M); pH = 5.0, 7.0 and 9.3 with phosphate buffers. S-18 Figure S8. Estimation of the radius of benzyl triazole functionalized amino-terminated PAMAM dendron (1-G1) using Chem Bio3D Ultra 11.0 (MMFF94 calculation) software. Figure S9. Estimation of the radius of benzyl triazole functionalized amino-terminated PAMAM dendron (2-G2) using Chem Bio3D Ultra 11.0 (MMFF94 calculation) software. S-19 Figure S10. Estimation of the radius of benzyl triazole functionalized amino-terminated PAMAM dendron (3-G3) using Chem Bio3D Ultra 11.0 (MMFF94 calculation) software. Using the Mansfield-Tomalia-Rakesh equation for parking spheres on a sphere, the maximum number of amino-terminated PAMAM dendrons that could be arranged around each nanoparticle was determined to be about 170, 105 and 55 for 1-G1, 2-G2 and 3-G3, respectively. Equation 1: r1/r2 > 1.20 r1 = 8nm, is the nanoparticle radius of starting azide-functionalized nanoparticles (determined from QELS). Even if the dendrons do not adopt a spherical geometry, we have estimated the radii of benzyl-triazole functionalized amino-terminated PAMAM dendrons considering that the dendrons have an extended conformation without correction for charge, solvation, etc using Chem Bio3D Ultra 11.0 (MMFF94 calculation) software. 1-G1 (r2 = 1.375 nm), 2-G2 (r2 = 1.825 nm), 3-(G3) (r2 = 2.76 nm) S-20 Table S2. Estimation of the maximum number (Nmax) of amino-terminated PAMAM dendrons grafted on the NP surface from the Equation 1 and number of charges per NP along with the estimation of the diameter of dendronized NPs. NP_PAMAM[NH2]4 NP_PAMAM[NH2]8 NP_PAMAM[NH2]16 Nmax 170 105 55 Number of primary amines per NP Number of tertiary amines per NP Number of (NH2 + N) per NP Number of (NH2 + N + CO-NH) per NP Number of positive charges per NP at neutral pHa Number of positive charges per NP at acidic pHb Calculated diameter (nm) of dendronized NPsc Measured diameter (nm) of dendronized NPsd 680 840 880 510 735 825 1190 1575 1705 2210 3045 3355 680 840 880 1190 1575 1705 21,5 23,3 27,05 20 24 27 a. Assuming complete protonation of the primary amine groups (pKa=7-9) b. Assuming complete protonation of the primary and tertiary amine groups (pKa=7-9 and 3-6 respectively) at pH ≤ 3. c. Calculated from the measured of the starting NP-N3 (16 nm) : D = DNP-N3 + 4*r2 d. Hydrodynamic diameter deduced from QELS measurements. S-21 Table S3. Estimation of the number of Bodipy grafted on the NP surface. NP_Bodipy_PAMAM[NH2]4a NP_Bodipy_PAMAM[NH2]8b NP_Bodipy_PAMAM[NH2]16c Number of NPsd 4,9 • 1018 5,1 • 1018 4,5 • 1018 Absorbance 0,30 (diluted 500 times) 0,26 (diluted 200 times) 0,25 (diluted 250 times) [Bodipy]e 1,88 0,66 0,79 Number of Bodipyf 1,1 • 1021 4,0 • 1020 4,8 • 1020 Number of Bodipyg 230 80 105 a. Polymer content 1,1 wt% b. Polymer content 1,15 wt% c. Polymer content 1,0 wt% d. Contained in 1L of the suspension e. Concentration of the Bodipy (mmol.L-1) in the suspension assuming an = 80 000 L.mol-1.cm-1 f. Contained in 1L of the suspension g. Grafted on the NP surface The number of nanoparticles (NPs) contained in 1L of the suspension was estimated assuming a size of 16 nm for the nanoparticle and a polymer density of 1.05. We have considered that all the mass of the dendronized nano-object is concentrated in the polystyrene nanoparticle core. The volume of the NP was calculated considering a spherical nanostructure and was estimated to be about 2,2 • 1018 cm3. S-22